Syndax Pharmaceuticals Statistics

Total Valuation

SNDX has a market cap or net worth of $1.16 billion. The enterprise value is $1.04 billion.

Market Cap	1.16B
Enterprise Value	1.04B

Important Dates

The last earnings date was Monday, August 4, 2025, after market close.

Earnings Date	Aug 4, 2025
Ex-Dividend Date	n/a

Share Statistics

SNDX has 86.14 million shares outstanding. The number of shares has increased by 10.11% in one year.

Current Share Class	86.14M
Shares Outstanding	86.14M
Shares Change (YoY)	+10.11%
Shares Change (QoQ)	+0.19%
Owned by Insiders (%)	0.66%
Owned by Institutions (%)	109.89%
Float	77.05M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	14.86
Forward PS	6.54
PB Ratio	7.35
P/TBV Ratio	7.36
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	13.29
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.71, with a Debt / Equity ratio of 2.19.

Current Ratio	4.71
Quick Ratio	4.48
Debt / Equity	2.19
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-16.35

Financial Efficiency

Return on equity (ROE) is -113.22% and return on invested capital (ROIC) is -45.16%.

Return on Equity (ROE)	-113.22%
Return on Assets (ROA)	-39.49%
Return on Invested Capital (ROIC)	-45.16%
Return on Capital Employed (ROCE)	-70.17%
Revenue Per Employee	$288,641
Profits Per Employee	-$1.24M
Employee Count	270
Asset Turnover	0.15
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -31.52% in the last 52 weeks. The beta is 0.73, so SNDX's price volatility has been lower than the market average.

Beta (5Y)	0.73
52-Week Price Change	-31.52%
50-Day Moving Average	10.26
200-Day Moving Average	13.09
Relative Strength Index (RSI)	74.13
Average Volume (20 Days)	2,630,016

Short Selling Information

The latest short interest is 23.90 million, so 27.75% of the outstanding shares have been sold short.

Short Interest	23.90M
Short Previous Month	23.69M
Short % of Shares Out	27.75%
Short % of Float	31.02%
Short Ratio (days to cover)	13.24

Income Statement

In the last 12 months, SNDX had revenue of $77.93 million and -$334.99 million in losses. Loss per share was -$3.89.

Revenue	77.93M
Gross Profit	-185.42M
Operating Income	-339.05M
Pretax Income	-264.08M
Net Income	-334.99M
EBITDA	-339.05M
EBIT	-339.05M
Loss Per Share	-$3.89

Full Income Statement

Balance Sheet

The company has $468.71 million in cash and $345.52 million in debt, giving a net cash position of $123.18 million or $1.43 per share.

Cash & Cash Equivalents	468.71M
Total Debt	345.52M
Net Cash	123.18M
Net Cash Per Share	$1.43
Equity (Book Value)	157.42M
Book Value Per Share	1.83
Working Capital	418.69M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-302.67M
Capital Expenditures	n/a
Free Cash Flow	-302.67M
FCF Per Share	-$3.51

Full Cash Flow Statement

Margins

Gross Margin	-237.92%
Operating Margin	-435.06%
Pretax Margin	-429.84%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SNDX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.11%
Shareholder Yield	-10.11%
Earnings Yield	-28.91%
FCF Yield	-26.12%

Dividend Details

Analyst Forecast

The average price target for SNDX is $36.58, which is 171.97% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$36.58
Price Target Difference	171.97%
Analyst Consensus	Strong Buy
Analyst Count	12
Revenue Growth Forecast (5Y)	93.93%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SNDX has an Altman Z-Score of -2.3 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.3
Piotroski F-Score	3